Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrina Kretsinger

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 15, 2006
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnelKatrina Kretsinger, Karen R Broder, Margaret M Cortese, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort studyJohn A Crump, Katrina Kretsinger, Kathryn Gay, et al.
Disaster Medicine and Public Health Preparedness|August 5, 2008
Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health PreparednessLouisa E Chapman, Ernest E Sullivent, Lisa A Grohskopf, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|August 1, 2008
Recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings and other mass-casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention (CDC)Louisa E Chapman, Ernest E Sullivent, Lisa A Grohskopf, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|March 25, 2006
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)Karen R Broder, Margaret M Cortese, John K Iskander, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Journal of Global Health|April 30, 2026
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodologySara Sá Silva, Melissa Ko, Thomas Cherian, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
Progress Toward Regional Measles Elimination - Worldwide, 2000-2020Meredith G Dixon, Matt Ferrari, Sebastien Antoni, et al.
The Lancet. Child & Adolescent Health|April 3, 2025
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trialTakudzwa S Sayi, Umid M Sharapov, Zachary Matson, et al.
Vaccines|November 26, 2024
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and ConsiderationsDarin Zehrung, Bruce L Innis, Auliya A Suwantika, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 15, 2006
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnelKatrina Kretsinger, Karen R Broder, Margaret M Cortese, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort studyJohn A Crump, Katrina Kretsinger, Kathryn Gay, et al.
Disaster Medicine and Public Health Preparedness|August 5, 2008
Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health PreparednessLouisa E Chapman, Ernest E Sullivent, Lisa A Grohskopf, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|August 1, 2008
Recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings and other mass-casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention (CDC)Louisa E Chapman, Ernest E Sullivent, Lisa A Grohskopf, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|March 25, 2006
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)Karen R Broder, Margaret M Cortese, John K Iskander, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Journal of Global Health|April 30, 2026
Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodologySara Sá Silva, Melissa Ko, Thomas Cherian, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
Progress Toward Regional Measles Elimination - Worldwide, 2000-2020Meredith G Dixon, Matt Ferrari, Sebastien Antoni, et al.
The Lancet. Child & Adolescent Health|April 3, 2025
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trialTakudzwa S Sayi, Umid M Sharapov, Zachary Matson, et al.
Vaccines|November 26, 2024
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and ConsiderationsDarin Zehrung, Bruce L Innis, Auliya A Suwantika, et al.
Pageof 6